Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Administer TeleHealth Med GLP-1 once weekly on the same day each week
Semegalutide is FDA-approved for the treatment of diabetes, obesity-related health conditions, and chronic weight management (specifically Wegovy) and is safely prescribed off-label for weight loss
:format(webp))
Clinical Trial Evidence and Weight Loss Outcomes A Phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) showed approximately 24% mean body weight reduction at the highest dose (12 mg) over 48 weeks
Injection Site Reactions Minor injection site reactions including redness, itching, or swelling affect a small percentage of users
Mounjaro represents a genuine breakthrough in medical weight loss, with clinical results that rival surgical interventions
Its typically reversible, Dr
